{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:31:45Z","timestamp":1792445505080,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41401-026-01792-y","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:44:23Z","timestamp":1777016663000},"page":"2268-2281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dopamine abrogates immunosuppression mediated by PD-L1 of cancer stem cells in a preclinical triple-negative breast cancer model"],"prefix":"10.1038","volume":"47","author":[{"given":"Jun-sheng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-zhe","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-ze","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"1792_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00213-005-0269-z","volume":"185","author":"T McMorris","year":"2006","unstructured":"McMorris T, Harris RC, Swain J, Corbett J, Collard K, Dyson RJ, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology. 2006;185:93\u2013103.","journal-title":"Psychopharmacology"},{"key":"1792_CR2","doi-asserted-by":"crossref","unstructured":"Hao FR, Wang SY, Zhu X, Xue JS, Li JY, Wang LJ, et al. Pharmacokinetic-pharmacodynamic modeling of the anti-tumor effect of sunitinib combined with dopamine in the human non-small cell lung cancer xenograft. Pharm Res. 2017;34:408\u201318.","DOI":"10.1007\/s11095-016-2071-5"},{"key":"1792_CR3","doi-asserted-by":"crossref","unstructured":"Ma YH, Wang SY, Ren YP, Li J, Guo TJ, Lu W, et al. Antitumor effect of axitinib combined with dopamine and PK-PD modeling in the treatment of human breast cancer xenograft. Acta Pharmacol Sin. 2019;40:243\u201356.","DOI":"10.1038\/s41401-018-0006-x"},{"key":"1792_CR4","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-07-1778","volume":"14","author":"C Sarkar","year":"2008","unstructured":"Sarkar C, Chakroborty D, Chowdhury UR, Dasgupta PS, Basu S. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res. 2008;14:2502\u201310.","journal-title":"Clin Cancer Res"},{"key":"1792_CR5","doi-asserted-by":"crossref","unstructured":"Wang SY, Mou ZZ, Ma YH, Li J, Li JY, Ji XW, et al. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: involvement of eradicating cancer stem-like cells. Biochem Pharmacol. 2015;95:98\u2013109.","DOI":"10.1016\/j.bcp.2015.03.013"},{"key":"1792_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1208\/s12248-020-0428-5","volume":"22","author":"SY Wang","year":"2020","unstructured":"Wang SY, Zhu X, Han MY, Hao FR, Lu W, Zhou TY. Mechanistic pharmacokinetic\/pharmacodynamic model of sunitinib and dopamine in MCF-7\/Adr xenografts: linking cellular heterogeneity to tumour burden. AAPS J. 2020;22:45.","journal-title":"AAPS J"},{"key":"1792_CR7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.7150\/jca.27780","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Wang ZB, Luo C, Mao XY, Li X, Yin JY, et al. The prospective value of dopamine receptors on bio-behavior of tumor. J Cancer. 2019;10:1622\u201332.","journal-title":"J Cancer"},{"key":"1792_CR8","doi-asserted-by":"crossref","unstructured":"Xue JS, Wang SY, Hao FR, Tian XY, Su H, Yang L, et al. Dopamine increases the anti-cancer efficacy of sunitinib in the treatment of pancreatic cancer. J Chin Pharm Sci. 2020;29:689\u2013700.","DOI":"10.5246\/jcps.2020.10.064"},{"key":"1792_CR9","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.7150\/jca.20850","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu QF, Liao Q, Zhao YP. Potential roles of peripheral dopamine in tumor immunity. J Cancer. 2017;8:2966\u201373.","journal-title":"J Cancer"},{"key":"1792_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol. 2016;216:42\u201389.","journal-title":"Acta Physiol"},{"key":"1792_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21:526\u201336.","journal-title":"Nat Rev Cancer"},{"key":"1792_CR12","doi-asserted-by":"crossref","unstructured":"Chen YS, Yan SM, Pu ZY, Feng JZ, Tan LK, Li YZ, et al. Dopamine signaling promotes tissue-resident memory differentiation of CD8+ T cells and antitumor immunity. Cancer Res. 2022;82:3130\u201342.","DOI":"10.1158\/0008-5472.CAN-21-4084"},{"key":"1792_CR13","doi-asserted-by":"crossref","unstructured":"Qin T, Wang CL, Chen XW, Duan CF, Zhang XY, Zhang J, et al. Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma. Toxicol Appl Pharmacol. 2015;286:112\u201323.","DOI":"10.1016\/j.taap.2015.03.021"},{"key":"1792_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1189\/jlb.5A1113-626RR","volume":"97","author":"J Wu","year":"2015","unstructured":"Wu J, Zhang RH, Tang N, Gong ZZ, Zhou JF, Chen YW, et al. Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity. J Leukoc Biol. 2015;97:191\u2013200.","journal-title":"J Leukoc Biol"},{"key":"1792_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40487-025-00346-2","volume":"13","author":"E Tiberi","year":"2025","unstructured":"Tiberi E, Parisi A, Pistelli M, Savini A, Galassi F, Reschini C, et al. Immunotherapy in triple-negative breast cancer. Oncol Ther. 2025;13:547\u201375.","journal-title":"Oncol Ther"},{"key":"1792_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.20892\/j.issn.2095-3941.2018.0209","volume":"16","author":"HZ Sun","year":"2019","unstructured":"Sun HZ, Yao N, Cheng SQ, Li LQ, Liu SQ, Yang Z, et al. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer. Cancer Biol Med. 2019;16:299\u2013311.","journal-title":"Cancer Biol Med"},{"key":"1792_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, Monge C, Yang YZ, Takebe N. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2020;17:204\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"1792_CR18","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234:8381\u201395.","journal-title":"J Cell Physiol"},{"key":"1792_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"1792_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.reth.2021.02.006","volume":"17","author":"H Tsuchiya","year":"2021","unstructured":"Tsuchiya H, Shiota G. Immune evasion by cancer stem cells. Regen Ther. 2021;17:20\u201333.","journal-title":"Regen Ther"},{"key":"1792_CR21","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.1818210116","volume":"116","author":"A Miranda","year":"2019","unstructured":"Miranda A, Hamilton PT, Zhang AW, Pattnaik S, Becht E, Mezheyeuski A, et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc Natl Acad Sci USA. 2019;116:9020\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1792_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01050-w","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang ZX, Chen YX, Wu HX, Yin L, Zhao Q, et al. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response. Genome Med. 2022;14:45.","journal-title":"Genome Med"},{"key":"1792_CR23","doi-asserted-by":"crossref","unstructured":"Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med. 2017;377:2500\u20131.","DOI":"10.1056\/NEJMc1713444"},{"key":"1792_CR24","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41401-021-00701-9","volume":"43","author":"L Yong","year":"2022","unstructured":"Yong L, Yao Y, Chen GS, Yan XX, Guo YC, Han MY, et al. QAP14 suppresses breast cancer stemness and metastasis via activation of dopamine D1 receptor. Acta Pharmacol Sin. 2022;43:1001\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"1792_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/carcin\/bgac045","volume":"43","author":"CE Grant","year":"2022","unstructured":"Grant CE, Flis AL, Ryan BM. Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis. 2022;43:517\u201327.","journal-title":"Carcinogenesis"},{"key":"1792_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos E, Risueno RM, Laronde S, Shapovalova Z, Lee JH, Russell J, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell. 2012;149:1284\u201397.","journal-title":"Cell"},{"key":"1792_CR27","doi-asserted-by":"publisher","first-page":"101042831771927","DOI":"10.1177\/1010428317719272","volume":"39","author":"J Zou","year":"2017","unstructured":"Zou J, Li H, Huang Q, Liu X, Qi X, Wang Y, et al. Dopamine-induced SULT1A3\/4 promotes EMT and cancer stemness in hepatocellular carcinoma. Tumour Biol. 2017;39:1010428317719272.","journal-title":"Tumour Biol"},{"key":"1792_CR28","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/s41388-019-0700-2","volume":"38","author":"L Castagnoli","year":"2019","unstructured":"Castagnoli L, Cancila V, Cordoba-Romero SL, Faraci S, Talarico G, Belmonte B, et al. WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer. Oncogene. 2019;38:4047\u201360.","journal-title":"Oncogene"},{"key":"1792_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1529847","volume":"16","author":"F Verona","year":"2025","unstructured":"Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G, et al. Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction. Front Immunol. 2025;16:1529847.","journal-title":"Front Immunol"},{"key":"1792_CR30","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/onc.2015.369","volume":"35","author":"DC Borcherding","year":"2016","unstructured":"Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, et al. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. 2016;35:3103\u201313.","journal-title":"Oncogene"},{"key":"1792_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep45686","volume":"7","author":"K Minami","year":"2017","unstructured":"Minami K, Liu SZ, Liu Y, Chen A, Wan QQ, Na S, et al. Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis. Sci Rep. 2017;7:45686.","journal-title":"Sci Rep"},{"key":"1792_CR32","doi-asserted-by":"crossref","unstructured":"Yang L, Yao Y, Yong L, Feng YY, Su H,Yao QY, et al. Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness. Eur J Pharmacol. 2019;859:172499.","DOI":"10.1016\/j.ejphar.2019.172499"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01792-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:41:37Z","timestamp":1784623297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01792-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}